Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06878911 · ClinicalTrials.gov registry record · NA
Clinical Validation of Nerveblox, an Artificial Intelligence Software to Support Ultrasound-Guided Regional Anesthesia Procedures
A NA study of Ultrasound Imaging of Anatomical Structures, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06878911: Completed NA study of Ultrasound Imaging of Anatomical Structures, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
NCT06878911 is a NA study of Ultrasound Imaging of Anatomical Structures that has completed, run by Smart Alfa Teknoloji San. ve Tic. A.S.. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06878911, a NA study of Ultrasound Imaging of Anatomical Structures, has completed, sponsored by Smart Alfa Teknoloji San. ve Tic. A.S..
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, prospective study is being conducted at AABP Integrative Pain Care and Wellness in Brooklyn, New York, USA. The aim of this study is to collect ultrasound images from healthy volunteers and evaluate the performance of the Nerveblox software using this image dataset. Nerveblox is a software as a medical device which is designed to assist anesthesiologist for ultrasound-guided regional anesthesia, prior to needling procedure.
Primary Outcome
The proportion of structures correctly identified by the software to all structures
Conditions Studied
Interventions
- DEVICE Ultrasound Scans
Study Locations (1)
New York
- AABP Integrative Pain Care and Wellness Clinic - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2025-02-23 |
| Phase | NA |
What the finished NCT06878911 record still lists
NCT06878911 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Ultrasound Imaging of Anatomical Structures appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound Scans is the first listed.
NCT06878911 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06878911 about?
NCT06878911 is a clinical study titled "Clinical Validation of Nerveblox, an Artificial Intelligence Software to Support Ultrasound-Guided Regional Anesthesia Procedures". This single-center, prospective study is being conducted at AABP Integrative Pain Care and Wellness in Brooklyn, New York, USA. The aim of this study is to collect ultrasound images from healthy volunteers and evaluate the performance of the Nerveblox software using this image dataset. Nerveblox is ...
What is the current status of trial NCT06878911?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-13. Estimated completion is 2025-02-23.
What conditions does trial NCT06878911 study?
This clinical trial studies the following conditions: Ultrasound Imaging of Anatomical Structures.
What interventions are being tested in trial NCT06878911?
The interventions under investigation include: Ultrasound Scans (DEVICE).
Who is sponsoring clinical trial NCT06878911?
This trial is sponsored by Smart Alfa Teknoloji San. ve Tic. A.S., which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06878911 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06878911's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI